Fabiflu(Search results - 2)
IndiaAug 6, 2020, 4:56 PM IST
Glenmark to launch 400 mg of antiviral drug FabiFlu for COVID-19 treatment
The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a statement.
IndiaJun 21, 2020, 5:56 PM IST
Coronavirus: Glenmark launches drug Favipiravir to treat mild to moderate COVID-19 cases
In a major coronavirus treatment breakthrough, Glenmark Pharmaceuticals' FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19.